Literature DB >> 27790499

A Case of Macrophage Activation Syndrome with Acute Respiratory Distress Syndrome.

Robin George Manappallil1.   

Abstract

Macrophage Activation Syndrome (MAS) is a rare form of Haemophagocytic Lymphohistiocytosis (HLH) associated with rheumatologic conditions. It is characterised by haemophagocytosis and cytokine overproduction, resulting from the activation and uncontrolled proliferation of T lymphocytes and macrophages. The patient being reported is an elderly female with Rheumatoid Arthritis (RA), who presented with fever and was found to have MAS. She later developed Acute Respiratory Distress Syndrome (ARDS) and died. Such a scenario has rarely been reported.

Entities:  

Keywords:  Haemophagocytic lymphohistiocytosis; Rheumatoid arthritis

Year:  2016        PMID: 27790499      PMCID: PMC5071999          DOI: 10.7860/JCDR/2016/20902.8518

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

Review 1.  Modern management of children with haemophagocytic lymphohistiocytosis.

Authors:  Gritta E Janka; E M Schneider
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

Review 2.  Histiocyte disorders.

Authors:  Jan Inge Henter; Carlo Tondini; Jon Pritchard
Journal:  Crit Rev Oncol Hematol       Date:  2004-05       Impact factor: 6.312

3.  Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.

Authors:  Normi Bruck; Meinolf Suttorp; Maria Kabus; Georg Heubner; Manfred Gahr; Frank Pessler
Journal:  J Clin Rheumatol       Date:  2011-01       Impact factor: 3.517

4.  Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.

Authors:  Tomoko Henzan; Koji Nagafuji; Hiroshi Tsukamoto; Toshihiro Miyamoto; Hisashi Gondo; Shinsaku Imashuku; Mine Harada
Journal:  Am J Hematol       Date:  2006-01       Impact factor: 10.047

5.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.

Authors:  J I Henter; G Elinder; A Ost
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

Review 6.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

7.  Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.

Authors:  Matthew P Strout; Stuart Seropian; Nancy Berliner
Journal:  Nat Rev Clin Oncol       Date:  2010-04-20       Impact factor: 66.675

8.  Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.

Authors:  Rebecca L Olin; Kim E Nichols; Mojdeh Naghashpour; Mariusz Wasik; Brenda Shelly; Edward A Stadtmauer; Dan T Vogl
Journal:  Am J Hematol       Date:  2008-09       Impact factor: 10.047

  8 in total
  2 in total

Review 1.  Autoinflammatory disease in the lung.

Authors:  Thomas Scambler; Jonathan Holbrook; Sinisa Savic; Michael F McDermott; Daniel Peckham
Journal:  Immunology       Date:  2018-04-19       Impact factor: 7.397

2.  Umbilical Cord-derived Mesenchymal Stem Cells with Surfactant Protein B Alleviates Inflammatory Response in Acute Respiratory Distress Syndrome by Regulating Macrophage Polarization.

Authors:  Hongtao Xu; Guoming Nie; Taiyong Yin; Cui Shao; Dongsheng Ding; Minshu Zou
Journal:  Balkan Med J       Date:  2022-03-14       Impact factor: 2.021

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.